Report on Antihypertensive Drug Market

Date: May 22, 2009
Pages: 15
Price:
US$ 550.00
Publisher: SunFaith China Ltd.
Report type: Brief Review
Delivery: E-mail Delivery (PDF)
ID: R6E3B182317EN
Leaflet:

Download PDF Leaflet

Report on Antihypertensive Drug Market
It is learned that China's hypertension morbidity rate of adults is 18.8%, treatment rate is 6.1%, and it also takes on a lowering trend of age, which attracting more and more people's attention on hypertension. Thus there is a greater demand for antihypertensive drug, and China's market scale of antihypertensive drug is still very huge in the future. This report carries out specific analysis and research of three major antihypertensive drug types, i.e.classification of current hypertension, and drug market competition. It points out that although there is a huge market demand of antihypertensive drug, the competition is still fierce.
1 INTRODUCTION OF HYPERTENSION

1.1 Classification
1.2 Types of antihypertensive drug

2 MARKET ANALYSIS OF ANTIHYPERTENSIVE DRUG

2.1 Market scale
2.2 Subdivison of market share
2.3 Market competition

3 CCB HYPOTENSOR

3.1 Amlodipine
3.2 Nifedipine
3.3 Felodipine

4 ARB HYPOTENSOR

4.1 Valsartan
4.2 Losartan Potassium
4.3 Irbesartan

5 BETA-BLOCKER HYPOTENSOR

5.1 Potassium magnessium aspartape
5.2 Metoprolol

6 ANALYSIS OF ANTIHYPERTENSIVE DRUG MARKET DEMAND

6.1 China's rising morbidity rate of hypertension
6.2 Low hypertension treatment rate and control rate
6.3 Huge market demand for antihypertensive drug

7 CONCLUSION
Skip to top


Cardiovascular Drugs: Market Research Report US$ 4,450.00 Apr, 2010 · 1058 pages
Anti-Hypertensive Drugs: Market Research Report US$ 3,950.00 Feb, 2010 · 893 pages
Chinese Markets for Cardiovascular Drugs US$ 4,000.00 Sep, 2012 · 240 pages

Ask Your Question

Report on Antihypertensive Drug Market
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: